Target intelligence / Profile preview

Zinc finger BED-type containing 10, pseudogene (ZBED10P)

Target
ZBED10P
Molecular classification
Other (Pseudogene), Zinc finger protein family (by homology and domain classification), Not an active enzyme, receptor, transporter, ion channel, or classical transcription factor.
01

Overview

ZBED10P (Zinc finger BED-type containing 10, pseudogene) is classified by the HUGO Gene Nomenclature Committee (HGNC) as a pseudogene located on human chromosome 7, previously termed C7orf29 and ZBED6CL[4][5]. It is part of the zinc finger BED-type protein family by sequence homology, sharing conserved domains with active ZBED proteins, but is considered non-functional as it does not encode a fully functional protein product. Pseudogenes, like ZBED10P, are remnants of once-functional genes, typically arising via gene duplication or retrotransposition, which have lost protein-coding ability due to frameshifts, early stop codons, or loss of regulatory elements[4][5]. There is no evidence of active translation of ZBED10P or physiological function, nor of any pharmacological or clinical relevance. Although some pseudogenes may regulate other genes at the RNA level, no such activity has been attributed to ZBED10P specifically. It is not considered a specific molecular target in therapeutic contexts.

Other names
ZBED10PC7orf29ZBED6CLZinc finger BED-type containing 10 pseudogeneZBED6 C-terminal-like proteinPutative protein ZBED10P
02

Mechanism of action

Not applicable (pseudogene, not a drug target)

03

Biological functions

None established; pseudogenes do not generally encode active proteins or have functional rolesSome pseudogenes may have regulatory RNA functions, but no such role has been clearly documented for ZBED10P.
04

Disease associations

Diseases listed in association with ZBED10P include Uremic Neuropathy and Hypophosphatasia, Infantile—but these are often gene locus associations rather than demonstrated functional linksNo established role in cancer, inflammation, neurodegeneration, cardiovascular disease, or infection
05

Safety considerations

None documented, as it is not a drug target or associated with therapeutic modulation
06

Interacting drugs

None (there are no documented drugs that target ZBED10P, as it is a pseudogene)
07

Biomarkers

None established or used clinically; it is not considered for patient selection or efficacy monitoring

Beyond the preview

Go deeper on Zinc finger BED-type containing 10, pseudogene (ZBED10P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger BED-type containing 10, pseudogene (ZBED10P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call